Clinical Trials Browser

Completed × Central Nervous System Neoplasms × trebananib × Clear all

NCT01538095 2016-10-03

Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors

Phase 1 Completed

Central Nervous System Neoplasms